Shareholder structure

NNIT's nominal share capital is DKK 250,000,000 divided into 25,000,000 shares with a nominal value of DKK 10 each.

No shares carry special rights and thus all shares rank pari passu in respect of voting rights, pre-emption rights, redemption and conversion and in respect of eligibility to receive dividends or proceeds in the event of dissolution and liquidation.

All shares are issued and fully paid up.

Each share of a nominal value of DKK 10 gives the holder the right to ten votes at general meetings.

NNIT has not issued any securities that are convertible, exchangeable nor have warrants attached.

The following chart outlines the information regarding the NNIT ownership structure.

Major shareholders

In accordance with section 55 of the Danish Companies Act and section 29 in the Danish Securities Act, the following investors have reported holding more than 5 percent of NNIT's share capital:

Novo Holdings A/S 25.50% (directly)
Novo Nordisk A/S 25.50% (directly)
Chr. Augustinus Fabrikker Akst. 10.0% (directly)
FMR Co. Inc 5.30% (directly)

Novo Holdings A/S has 51 percent indirect ownership through its holding of Novo Nordisk A/S.
FMR LLC has 6.31 percent indirect ownership through its holding of FMR Co. Inc. as well as other subsidiaries.

Investor relations contact

Jesper Wagener
Head of Investor Relations

Email
+45 3075 5392

Email alerts

To subscribe to receive updates by email.

Subscribe

Follow NNIT